
Sign up to save your podcasts
Or
How can community-based oncologists leverage the newest therapies for patients with heavily relapsed/refractory myeloma? Credit available for this activity expires: 4/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991105?ecd=bdc_podcast_libsyn_mscpedu
4.3
2323 ratings
How can community-based oncologists leverage the newest therapies for patients with heavily relapsed/refractory myeloma? Credit available for this activity expires: 4/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991105?ecd=bdc_podcast_libsyn_mscpedu
13 Listeners
319 Listeners
97 Listeners
160 Listeners
862 Listeners
494 Listeners
692 Listeners
18 Listeners
272 Listeners
254 Listeners
3,321 Listeners
135 Listeners
1,082 Listeners
7,955 Listeners
186 Listeners
59 Listeners
8 Listeners
415 Listeners
314 Listeners